BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9268229)

  • 1. Cardiac heparin-releasable lipoprotein lipase activity in fructose-hypertensive rats: effect of coronary vasodilation.
    Sambandam N; Lim F; Cam MC; Rodrigues B
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):110-7. PubMed ID: 9268229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac lipoprotein lipase in the spontaneously hypertensive rat.
    Sambandam N; Chen X; Cam MC; Rodrigues B
    Cardiovasc Res; 1997 Feb; 33(2):460-8. PubMed ID: 9074711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
    Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
    Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
    Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
    Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
    Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
    Rodrigues B; Severson DL
    Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid changes in rat heart lipoprotein lipase activity after feeding carbohydrate.
    Pedersen ME; Schotz MC
    J Nutr; 1980 Mar; 110(3):481-7. PubMed ID: 7359219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE; Severson DL
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitoyl lysophosphatidylcholine mediated mobilization of LPL to the coronary luminal surface requires PKC activation.
    Pulinilkunnil T; An D; Yip P; Chan N; Qi D; Ghosh S; Abrahani A; Rodrigues B
    J Mol Cell Cardiol; 2004 Nov; 37(5):931-8. PubMed ID: 15522270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase.
    An D; Pulinilkunnil T; Qi D; Ghosh S; Abrahani A; Rodrigues B
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E246-53. PubMed ID: 15328075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
    Carroll R; Juhasz A; Severson DL
    Biochem J; 1990 Sep; 270(2):391-5. PubMed ID: 2169239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
    Rodrigues B; Braun JE; Spooner M; Severson DL
    Can J Physiol Pharmacol; 1992 Sep; 70(9):1271-9. PubMed ID: 1493594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining.
    Pulinilkunnil T; Qi D; Ghosh S; Cheung C; Yip P; Varghese J; Abrahani A; Brownsey R; Rodrigues B
    Cardiovasc Res; 2003 Sep; 59(3):788-97. PubMed ID: 14499880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures.
    Chajek-Shaul T; Halimi O; Ben-Naim M; Stein O; Stein Y
    Biochim Biophys Acta; 1989 Nov; 1014(2):178-83. PubMed ID: 2554975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
    Braun JE; Severson DL
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does long-term metformin treatment increase cardiac lipoprotein lipase?
    Hauton D
    Metabolism; 2011 Jan; 60(1):32-42. PubMed ID: 20153488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG; Evans RD
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts.
    Severson DL; Lee M; Carroll R
    Mol Cell Biochem; 1988 Jan; 79(1):17-24. PubMed ID: 3374475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.